Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
New words:
adversarial, AG, aggressive, alter, anniversary, annuity, antagonist, antibody, array, assert, assignee, assumed, backup, billion, Biopharma, biosimilar, block, blocking, breadth, broad, brownian, cancellation, Carlo, certainty, cessation, checkpoint, circumvented, CMO, commonplace, conceived, conclusion, concurrent, concurrently, conferred, configured, consecutive, contrast, correct, counsel, crowded, cumulative, Curetech, curtail, cycle, declaratory, degree, desirable, desired, Display, dispute, distraction, documentary, dominant, downstream, dual, earliest, effort, envision, exacerbate, exceeding, familiarity, family, fee, flexibility, forma, found, Franc, freedom, functional, geometric, Germany, GITR, halt, hampered, hand, headcount, herpetic, identification, ii, iii, illustrative, impinge, implied, impractical, inadvertent, inadvertently, IND, indirectly, intangible, inter, introduce, inventor, inventorship, ipilimumab, IV, January, jeopardize, lag, landscape, lapse, lead, leading, leave, lesion, lifetime, literature, Ludwig, maintenance, managerial, Medimmune, misappropriate, missed, mix, modulator, molecular, monoclonal, monospecific, Monte, motion, narrowed, narrower, noncompliance, opposition, optimization, optimize, organized, pro, procedural, proceed, ramp, rapid, reactive, readout, Recepta, reexamination, reinstated, relief, remind, retired, Retrocyte, rightfully, SA, SEC, secret, sequence, shelf, shift, simulation, site, sought, Squibb, stable, suitable, supplemental, Switzerland, synergy, tangible, Tesaro, threat, throughput, treasury, trending, underwritten, unenforceable, unissued, unlikelihood, viability, vulnerability, yearly, Yervoy
Removed:
America, AOCI, BLA, brain, build, California, Canada, center, CEO, clarify, cognizant, consulting, consume, contemplated, contracted, creditable, dated, decision, detail, diminished, duration, enforced, enjoined, entirety, equivalent, ESPP, Europe, European, expectation, exploit, exploring, Francisco, free, generating, governed, HSP, identical, importing, instituted, invent, long, nonrefundable, offset, partially, passage, post, progression, proliferation, proposed, provoked, reclassification, reclassified, reference, reflected, reform, refuse, Restated, reviewing, San, screening, select, send, Separately, September, sizable, source, stopping, subcontract, subsequently, suggesting, survival, tested, thereon, thereunder, unclear, underway, untested, untried, upheld, violated, virtually, yielded
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Collaborative Research and Development Agreement
- 10.2 Collaborative Research and Development Agreement
- 10.3 Sublease Agreement
- 10.3.1 Amendment to Sublease
- 10.3.2 Amendment 4 to Sublease
- 10.3.3 Amendment 5 to Sublease
- 10.3.4 Amendment 6 to Sublease
- 10.4 Commercial Lease Agreement
- 10.4.1 Amendment 20 to Commercial Lease
- 10.4.2 Amendment 28 to Commercial Lease
- 10.4.3 Amendment 29 to Commercial Lease
- 31.1 Certificate of CEO Pursuant to Section 302
- 31.2 Certificate of Pfo Pursuant to Section 302
- 32.1 Certificate of CEO and Pfo Pursuant to Section 906
- Download Excel data file
- View Excel data file
Related press release
AGEN similar filings
Filing view
External links
Exhibit 32.1
Certification
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Agenus Inc. (the “Company”) for the quarterly period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned to his/her knowledge hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(i) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ GARO H. ARMEN, PH.D. | |
Garo H. Armen, Ph.d. | |
Chief Executive Officer and Principal Executive Officer | |
/s/ CHRISTINE M. KLASKIN | |
Christine M. Klaskin | |
VP, Finance and Principal Financial Officer |
Date: May 9, 2014
A signed original of this written statement required by Section 906 has been provided to Agenus Inc. and will be retained by Agenus Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2014 and should not be considered filed as part of the Quarterly Report on Form 10-Q.